Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 3/2013

01-03-2013 | Original Paper

Occurrence of New Sexually Transmitted Diseases in Males After HIV Diagnosis

Authors: Y. Omar Whiteside, Anwar T. Merchant, James Hussey, Swann Arp Adams, Wayne A. Duffus

Published in: AIDS and Behavior | Issue 3/2013

Login to get access

Abstract

Risk reduction following an HIV diagnosis is important for controlling the epidemic. The objective of this retrospective cohort study of 6,965 HIV-positive males was to evaluate the joint risk of new reportable STDs in males after HIV diagnosis by race/ethnicity and risk behavior. This investigation linked HIV case reports with STD surveillance, clinical care and laboratory datasets to determine new STD acquisition in HIV positive individuals. Compared to White MSM with high care engagement, Black MSM had a significantly higher rate of new reportable STDs for the full time period after HIV diagnosis, ≤1 year after diagnosis, and >1 year after diagnosis. High HIV care engagement was not as protective against new STD acquisition for Black MSM as it was for White MSM and reasons for this health disparity should be explored.
Literature
1.
Centers for Disease Control and Prevention. Sexually Transmitted Diseases Guidelines. MMWR. 2010;59(No. RR-12):1–116.
2.
Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, et al. Primary care guidelines for the management of persons infected with Human Immunodeficiency Virus: 2009 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:651–81.PubMedCrossRef
3.
Metsch LR, Pereyra M, Messinger S, del Rio C, Strathdee SA, Anderson-Mahoney P. HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. Clin Infect Dis. 2008;47:577–84.PubMedCrossRef
4.
Bachman LH, Grimley DM, Waithaka Y, Desmond R, Saag MS, Hook EW. Sexually tranmitted disease/HIV transmission risk behaviors and sexually transmitted disease prevalence among HIV-positive men receiving continuing care. Sex Transm Dis. 2005;32:20–6.CrossRef
5.
Kalichman KC, Rompa D, Cage M. Sexually transmitted infections among HIV seropositive men and women. Sex Transm Infect. 2000;76:350–4.PubMedCrossRef
6.
Onen NF, Shacham E, Stamm KE, Overton ET. Comparisons of sexual behaviors and STD prevalence among older and younger individuals with HIV infection. AIDS Care. 2010;22:711–7.PubMedCrossRef
7.
Lee HS, Ko NY, Lee NY, Chang CM, Liu SY, Ko WC. Trends in sexually transmitted diseases and risky behaviors among HIV-infected patients at an outpatient clinic in Southern Taiwan. Sex Transm Dis. 2010;37:86–92.PubMedCrossRef
8.
Wald A, Corey L, Handsfield HH, Holmes KK. Influence of HIV infection of manifestations and natural history of other sexually transmitted diseases. Annu Rev Public Health. 1993;14:19–42.PubMedCrossRef
9.
Erbelding EJ, Shang-En C, Kamb ML, Irwin KL, Rompalo AM. New sexually transmitted diseases in HIV-infected patients: markers for ongoing HIV transmission behavior. J Acquir Immune Defic Syndr. 2003;33:247–52.PubMedCrossRef
10.
Wasserheit JN. Epidemiologic synergy: interrelationships between Human Immunodeficiency Virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992;9:61–77.
11.
Machekano RN, Bassett MT, Zhou PS, Mbizvo MT, Latif AS, Katzenstein DA. Report of sexually transmitted diseases by HIV infected men during follow up: time to target the HIV infected? Sex Transm Infect. 2000;76:188–92.PubMedCrossRef
12.
Osewe PL, Peterman TA, Ransom RL, Zaidi AA, Wroten JE. Trends in the acquisition of sexually transmitted diseases among HIV-positive patients at STD clinics, Miami 1988–1992. Sex Transm Dis. 1996;23:230–3.PubMedCrossRef
13.
Hecht FM, Grant RM, Petropoulos CJ, Dillon B, Chesney MA, Tian H. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med. 1998;339:341–3.CrossRef
14.
Ramos A, Hu DJ, Nguyen L, Phan KO, Vanichseni S, Promadej N, et al. Intersubtype Human Immunodeficiency Virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol. 2002;76:7444–52.PubMedCrossRef
15.
Jost S, Bernard MC, Kaiser L, Yerly S, Hirschel B, Samri A, et al. A patient with HIV-1 superinfection. N Engl J Med. 2002;347:731–6.PubMedCrossRef
16.
Otten MW, Zaidi AA, Wroten JE, Witte JJ, Peterman TA. Changes in sexually transmitted disease rates after HIV testing and posttest counseling, Miami 1988 to 1989. Am J Public Health. 1993;83:529–32.PubMedCrossRef
17.
McNeil J, Sheffield JVL, Bartlett JG. Core elements of HIV primary care. In: Bartlett JG, Cheever LW, Johnson MP, Paauw DS, editors. A guide to the primary care of people with HIV/AIDS. Rockville, Maryland: U. S. Department of Health and Human Services Health Resources and Service Administration; 2004. p. 17.
18.
Allison PD. Convergence failures in logistic regression. Presented at San Antonio, TX, Paper 360–2008, SAS Global Forum, 16–19 March 2008.
19.
20.
Kent KK, Chaw JK, Wong W, Liska S, Gibson S, Hubbard G, et al. Prevalence of rectal, urethral, and pharyngeal Chlamydia and Gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis. 2005;41:67–74.PubMedCrossRef
21.
Rieg G, Lewis RJ, Miller LG, Witt MD, Guerrero M, Daar ES. Asymptomatic Sexually Transmitted Infections in HIV-infected men who have sex with men: prevalence, incidence, predictors and screening stages. AIDS Patient Care ST. 2008;22:947–54.CrossRef
22.
Gorbach PM, Weiss RE, Jeffries R, Javanbakht M, Drumright LN, Daar ES, et al. Behaviors of recently HIV-infected men who have sex with men in the year postdiagnosis: effects of drug use and partner type. J Acquir Immune Defic Syndr. 2011;56:176–82.PubMedCrossRef
23.
Magnus M, Kuo I, Phillips G., Shelley K, Rawls A, Peterson J et al. Elevated HIV prevalence despite lower rates of sexual risk behaviors among black men in the District of Columbia who have sex with men. AIDS Patient Care ST. 2010;24:615–22.
24.
25.
Hallfors DD, Iritani BJ, Miller WC, Bauer DJ. Sexual and drug behavior patterns and HIV and STD racial disparities: the need for new directions. Am J Public Health. 2007;97:125–32.PubMedCrossRef
26.
Rountree MA, Chen L, Brown A, Pomeroy EC. HIV testing rates and testing locations, by race and ethnicity. Health Soc Work. 2009;34:247–55.PubMedCrossRef
27.
Ebrahim SH, Anderson JE, Weidle P. Race/ethnic disparities in HIV testing and knowledge about treatment for HIV/AIDS: United States. AIDS Patient Care STDs. 2004;18:27–33.PubMedCrossRef
28.
Inunga JN. Potential barriers to seeking human immunodeficiency virus testing among adults in the United States: data from the 1998 National Health Interview Survey. AIDS Patient Care STDs. 2002;16:293–9.CrossRef
29.
Newman LM, Berman SM. Epidemiology of STD disparities in African American communities. Sex Transm Dis. 2008;35(12 Suppl):S4–12.PubMed
30.
Crosby R, Holtgrave DR, Stall R, Peterson JL, Shouse L. Differences in HIV risk behaviors among Black and White men who have sex with men. Sex Transm Dis. 2007;34:744–9.PubMed
31.
The White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States. Washington, DC: White House; 2010.
Metadata
Title
Occurrence of New Sexually Transmitted Diseases in Males After HIV Diagnosis
Authors
Y. Omar Whiteside
Anwar T. Merchant
James Hussey
Swann Arp Adams
Wayne A. Duffus
Publication date
01-03-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue 3/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-012-0142-0

Other articles of this Issue 3/2013

AIDS and Behavior 3/2013 Go to the issue

Original Paper

HIV Risk Behaviors Among Black/African American and Hispanic/Latina Female Partners of Men Who Have Sex With Men and Women

Original Paper

A Randomized Controlled Pilot Study of an HIV Risk-Reduction Intervention for Sub-Saharan African University Students

Original Paper

Unsafe Sex and STI Prevalence Among HIV-Infected Adults in Guangzhou, China: Opportunities to Deamplify Sexual HIV Transmission

Editorial Review

HIV Prevention Interventions for Adolescents and Young Adults: What About the Needs of Gay and Bisexual Males?

Brief Report

HIV Testing Among Patients Infected with Neisseria gonorrhoeae: STD Surveillance Network, United States, 2009–2010

Original Paper

Non-Injection and Injection Drug Use and STI/HIV Risk in the United States: The Degree to which Sexual Risk Behaviors Versus Sex with an STI-Infected Partner Account for Infection Transmission among Drug Users
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits